China NMPA Product Recall - Bupleurum
China NMPA product recall for Bupleurum by Xinjiang Bencaotang Pharmaceutical Co., Ltd. published November 01, 2018. Recall level: . The National Medical Products Administration (NMPA) issued a formal notice concerning a product reca
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Bupleurum by Xinjiang Bencaotang Pharmaceutical Co., Ltd. published November 01, 2018. Recall level: . The National Medical Products Administration (NMPA) issued a formal notice concerning a product reca
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox